Consolidated Statements of Operations - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2019 |
Dec. 31, 2018 |
|
| Income Statement [Abstract] | ||
| Net sales | $ 214,974 | $ 39,911 |
| Cost of sales | 112,431 | 9,391 |
| Gross profit | 102,543 | 30,520 |
| Operating expenses: | ||
| Selling and marketing | 1,061,676 | 1,165,631 |
| Administrative and general | 3,497,273 | 3,570,786 |
| Research and development | 1,371,433 | 1,361,154 |
| Depreciation and amortization | 65,902 | 50,765 |
| Total operating expenses | 5,996,284 | 6,148,336 |
| Total operating loss | (5,893,741) | (6,117,816) |
| Other expense: | ||
| Interest expense | (106,437) | (134,947) |
| Interest income | 36,652 | 19,804 |
| Gain on disposition of assets | 850 | |
| Net loss from investment in joint venture | (232,881) | (38,764) |
| Total other expense | (301,816) | (153,907) |
| Loss before income taxes | (6,195,557) | (6,271,723) |
| Provision for income taxes | ||
| Net loss | $ (6,195,557) | $ (6,271,723) |
| Net loss per share - basic and diluted | $ (0.36) | $ (0.50) |
| Weighted average shares - basic and diluted | 16,756,912 | 12,484,617 |